AHH – EFFECT March 30, 2026 In SEC https://www.sec.gov/Archives/edgar/data/1569187/999999999526000968/9999999995-26-000968-index.htm #AHH Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session SLNH – 10-K